BREAST CANCER METASTATIC
Clinical trials for BREAST CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER METASTATIC trials appear
Sign up with your email to follow new studies for BREAST CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental cancer drug trial halted midway
Disease control TerminatedThis study tested a drug called tusamitamab ravtansine in 50 adults with advanced breast or pancreatic cancer that had spread. The goal was to see if the drug could shrink tumors or slow the disease. The trial was stopped early, and results are limited.
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated May 26, 2026 03:14 UTC
-
New breast cancer drug shows promise in Late-Stage trial
Disease control TerminatedThis study tested a new drug called amcenestrant against standard hormone therapies for people with a common type of advanced breast cancer (ER+/HER2-). The goal was to see if amcenestrant could slow cancer growth better than usual treatments. The trial included 367 adults whose …
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated May 20, 2026 11:56 UTC